Furthermore, in obese mice with spontaneous onset of mammary tumors, ablation of T-cell STAT3, or treatment with FAO inhibitors, reduced FAO to increase glycolysis and CD8+ T effector cell function, thereby inhibiting mammary tumor development [77]. The gene discussed is STAT3; the disease is breast cancer.